TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1
Journal
Cancer Letters
Journal Volume
498
Pages
142-151
Date Issued
2021
Author(s)
SDGs
Publisher
Elsevier Ireland Ltd
Type
journal article